
Lung Neoplasms
Lung Neoplasms
How Lung Neoplasms Medications Work
Lung neoplasms, or lung cancers, are a complex and multifaceted disease. While surgery is the gold standard for treatment, medications play a crucial role in managing symptoms, slowing disease progression, and improving quality of life.
Medication Options
- Chemotherapy: Chemotherapy uses cytotoxic agents to kill cancer cells. It can be used as an alternative to surgery or in combination with other treatments. Common chemotherapy medications for lung neoplasms include platinum-based drugs (e.g., cisplatin) and non-platinum based drugs (e.g., pemetrexed).
- Targeted Therapy: Targeted therapy uses medications that specifically target molecular abnormalities in cancer cells, such as mutations or overexpression of certain proteins. Examples include EGFR inhibitors (e.g., erlotinib) and ALK inhibitors (e.g., crizotinib).
- Immunotherapy: Immunotherapy uses medications that stimulate the immune system to attack cancer cells. Checkpoint inhibitors (e.g., pembrolizumab) are a type of immunotherapy used in lung neoplasms.
How Medications Work
Medications for lung neoplasms work by targeting specific mechanisms involved in cancer cell growth and survival. Chemotherapy works by interfering with DNA replication, while targeted therapy blocks molecular pathways that promote tumor growth. Immunotherapy stimulates the immune system to recognize and attack cancer cells.
Important Considerations
When choosing a medication for lung neoplasms, it's essential to consider factors such as the type of lung cancer, stage of disease, patient's overall health, and potential side effects. A comprehensive treatment plan should be developed in consultation with a healthcare provider.